Mueller SC, Karasch I, Lakner J, Wacke R; Validation of an Isavuconazole High-Performance Liquid Chromatography Assay in Plasma for Routine Therapeutic Drug Monitoring Applications. Ther Drug Monit. 2018 Vol. 40 (4): 503 - 506. PMID: 29994987

Schmiedl S, Rottenkolber M, Szymanski J, Drewelow B, Siegmund W, Hippius M, Farker K, Guenther IR, Hasford J, Thuermann PA; German Net of Regional Pharmacovigilance Centers (NRPC). Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients. Expert Opin Drug Saf. 2018 Feb; 17(2): 125 - 137. PMID: 29258401

Brinkman DJ, Tichelaar J, Mokkink LB, Christiaens T, Likic R, Maciulaitis R, Costa J, Sanz EJ, Maxwell SR, Richir MC, van Agtmael MA; Education Working Group of the European Association for Clinical Pharmacology and Therapeutics (EACPT); its affiliated Network of Teachers in Pharmacotherapy (NOTIP). Key learning outcomes for clinical pharmacology and therapeutics education in Europe: A modified Delphi study. Clin Pharmacol Ther. 2018 Aug;104(2): 317-325. PMID: 29205299

Fiedler T, Rabe M, Mundkowski RG, Oehmcke-Hecht S. Adipose-derived mesenchymal stem cellsrelease microvesicles with procoagulant activity. Int J Biochem Cell Biol. 2018 May 17; 100: 49-53. doi: 10.1016/j.biocel.2018.05.008. [Epub ahead of print]. PMID: 29778527


Wulf K, Tschierschky U, Eickner T, Grabow N, Mundkowski RG. Studies on the interaction of polylactid-based planar and nanoparticular biomaterials with serum albumin and fibrinogen. Colloids Surf B Biointerfaces. 2017 Nov 1; 159:1 - 6. PMID: 28778061


Majcher-Peszynska J, Loebermann M, Klammt S, Frimmel S, Mundkowski RG, Welte T, Reisinger EC, Drewelow B, CAPNETZ Sudy Group. Ampicillin/sulbactam in elderly patients with community-acquired pneumonia. Infections. 2014 Feb; 42 (1): 79 – 87. PMID:23904004

Schmiedl S; Rottenkolber M; Hasford J; Rottenkolber D; Farker K; Drewelow B; Hippius M; Saljé K; Thürmann P. Self-Medication with Over-the-Counter and Prescribed Drugs Causing Adverse-Drug-Reaction-Related Hospital Admission: Results of a Prospektive, Long-Term Multi-Centre Study. Drug Saf (2014) Apr; 37 (4): 225 – 35. PMID: 24550104

Machka C; Lange S; Werner J; Wacke R; Killian D; Knueppel A; Knuebel G; Vogel H; LIndner I; Roolf C; Escobar HM; Junghanss C. Everolimus in combination with Mycophenolate Mofetil as pre- and post-transplant immunosuppression following non-myeloablative hematopoietic stem cell transplantation in canine littermates. Biol Blood Marrow Transplant. 2014 Jun 9. PMID 24923538

Drewelow B, Majcher-Peszynska J. Pharmakokinetik/Pharmakodynamik von Antibiotika - Können/müssen wir hier besser werden? Drug Res (Stuttg). 2014 Nov;64(S 01):S6-S7. Epub 2014 Nov 25. PMID: 25423431

Löffler C, Drewelow E, Paschka SD, Frankenstein M, Eger J, Jatsch L, Reisinger EC, Hallauer JF, Drewelow B, Heidorn K, Schröder H, Wollny A, Kundt G, Schmidt C, Altiner A. Optimizing polypharmacy among elderly hospital patients with chronic diseases¿study protocol of the cluster randomized controlled POLITE-RCT trial. Implement Sci. 2014 Oct 6;9(1):151. PMID: 25287853


Schmiedl S, Rottenkolber M, Szymanski J, SIegmund W, Hippius M, Farker K, Drewelow B, Hasford J, Thürmann P. Bleeding complications and liver injuries during Phenprocoumon treatment: a multiventre prospective observational study in internal medicine departments. Dtsch Arztebl Int. 2013 110 (14): 244 – 52. PMID: 23616817


Junghanss C, Rathsack S, Wacke R, Weirich V, Vogel H, Drewelow B, Mueller S, Altmann S, Freund M, Lange S. Everolimus in combination with cyclosporin a as pre- and posttransplantation immunosuppressive therapy in nonmyeloablative allogeneic hematopoietic stem cell transplantation. 2012; Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation; VOL: 18 (7); p. 1061-8 /201207/ PMID: 22182476

Müller S, März R, Schmolz M, Drewelow B, Eschmann K, Meiser P. Placebo-controlled Randomzed Clinical Trial on the Immunomodulating Activities of Low- and High-Dose Bromelain after Oral Administration – New Evidence on the Antiinflammatory Mode of Action of Bromelain. Phytother. Res. 2012; DOI 10.1002/ptr.4678. PMID 22517542

Mueller SC, März R, Schmolz M, Drewelow B. Intraindividual long term stability and response corridors of cytokines in healthy volunteers detected by a stanardized whole-blood culture system for bed-side applivation. BMC Med Res Methodol. 2012; Aug 1; 12(1): 112. PMID: 22853196

Mueller SC, Drewelow B. Evaluation of limited sampling models for prediction of oral midazolam AUC for CYP3A phenotyping and drug interaction studies. Eur J Clin Pharmacol. 2012; DOI 10.1007/s00228-012-1437-9 (ISSN 0031-6970) Schittkowski MP, Guthoff RF, Drewelow B, Wacke R. Hydrogelexpander as Drug Delivery System for Antibiotics. Klin Monbl Augenheilkd. 2012 Feb; 229(2):158-61. PMID: 21847785

Moeller S, Kegler, Sternberg K, Mundkowski RG. Influence of sirolimus-loaded nanoparticles on physiological functions of native human polymorphonuclear neurophils. 2012; Nanomedicin. 8 (8); p. 1293-300. PMID: 22321382

Lepper PM, Ott S, Nüesch E, von Eynatten M, Schumann C, Pletz MW, Mealing NM, Welte T, Bauer TT, Suttorp N, Jüni P, Bals R, Rohde G; German Community Acquired Pneumonia Competence Network. Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study. BMJ. 2012 May 28;344:e3397. doi: 10.1136/bmj.e3397. PMID: 22645184

Kolditz M, Höffken G, Martus P, Rohde G, Schütte H, Bals R, Suttorp N, Pletz MW; CAPNETZ study group. Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study. BMC Infect Dis. 2012 Apr 13;12:90. doi: 10.1186/1471-2334-12-90. PMID: 22501026     

Briesen S, Guthoff R, Kilangalanga N, Mundkowski RG. Counterfeiting of eye drops?: a laboratory study of antibiotic eye drops purchased in two African countries. Ophthalmologe. 2012 Dec;109(12):1207-10. doi: 10.1007/s00347-012-2651-7. German. PMID: 22972173


von Baum H., Schweiger B, Welte T, Marre R, Suttorp N, Pletz MW, Ewig S, CAPNETZ Study Group. How deadly is seasonal influenza-associatet pneumonia? The German Competence Network for Community-Acquired Pneumonia. Eur Respir J. 2011 May;37(5):1151-7. Epub2010 Sep 3. PMID:20817703

Majcher-Peszynska J, Sass M, Schipper S, Czaika V, Gussmann A, Lobmann R, Mundkowski R, Luebbert C, Kujath P, Ruf BR, Koch H, Schareck W, Klar E, Drewelow B. Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort. Eur J Clin Pharmacol. 2011 Feb;67(2): 135-42.Epub 2010 Sep 25.PubMed PMID: 20871984

Pletz MW, Rohde G, Schütte H, Bals R, Baum H, Welte T; CAPNETZ-Studiengruppe.Epidemiology and Aetiology of Community-acquired Pneumonia (CAP.Dtsch Med Wochenschr. 2011 Apr);136(15):775-80

Rottenkolber D, Schmiedl S, Rottenkolber M, Farker K, Siegmund W, Drewelow B, Hippius M, Thuermann P, Hasford J. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf. 2011 Mar 8. doi: 10.1002/pds.2118. [Epub ahead of print] PubMed PMID: 21384463. pharmacoepidemiology and drug safety 2011; 20: 626-634 

Wacke R, Drewelow B, Mundkowski RG, Guthoff RF, Schittkowski MP. In vitro Kinetics of Delivery of Tobramycin and Ofloxacin from Osmotic Hydro Gel Expanders. Int J Clin Pharmacol Ther. 2011 Jul;49(7):422-7


Szultka M, Kegler R, Fuchs P, Olszowy P, Miekisch W, Schubert JK, Buszewski B: Polypyrrole solid phase microextraction: a new approach to rapid sample preparation for the monitoring of antibiotic drugs. Analytica Chimica Acta. 2010, 667 (1-2): 77 - 82

Drewelow B, Schaffler K; Reitmeir P; Bethke T D: Effects of multiple-dose esomeprazole and pantoprazole on diazepam pharmacokinetic profile and pharmacodynamic effects on cognitive and psychomotor function in healthy volunteers. Arzneimittelforschung 2010, 60 (8): 483 - 491

Majcher-Peszynska J, Sass M, Schipper S, Czaika V, Gussmann A, Lobmann R, Mundkowski R, Luebbert C, Kujath P, Ruf BR, Koch H, Schareck W, Klar E, Drewelow B. Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort. Eur J Clin Pharmacol 2010;DOI 10.1007/s00228-010-0903-5

Kresken M, Decker-Burgard S, Drewelow B, Majcher-Peszynska J, Pletz MWR, Welte T. Carbepeneme im Vergleich-Stelenwert von Doripenem. Chemotherapie Journal 2010;131-149

Drewelow B;Reisinger E: Pharmakotherapie. Klinische Pharmakologie, 2010, Springer-Verlag, ISBN 978-3-642-10540-1, S. 121-153


Mueller SC; Majcher-Peszynska J; Mundkowski RG; Uehleke B; Klammt S; Sievers H; LehnfeldR; Frank B; Thurow K; Kundt G; Drewelow B: No cilincally relevant CYP3A induction after St. Johns wort with low hyperforin content in healthy volunteers. Eur J Clin Pharmacol, 2009, 65 (1): 81 - 87 (2008: DOI 10.1007/s00228-008-0554-y)

Reuss R; Reuter I; Jaus M; Fischer F, Mueller SC; Stolz E: Torticollis under cyclobenzaprine. Pharmacology, 2009, 84 (2): 91-2

Wiessner R; Eisold S; Linnebacher M; Bünger C; Nizze H; Wacke R; Benz S; Schareck W; Klar E: Up-Regulantion of ICAM-1 During Cold Inschemia Triggers Early Neutrophil Infiltration in Human Pankreas Allograft Reperfusion. Transplantation Proceedings, 2009, 41, 3622 - 3627

Peszynska J., Drewelow B. Sturzassoziierte Medikation und Polypharmakotherapie im Alter. Ärzteblatt Mecklenburg - Vorpommern, 12/2009


Barth J; Jäger D; Mundkowski R; Drewelow B; Welte T; Burkhardt O: Single- and multiple-dose pharmacokinetics of intravenous moxifloxacin in patients with severe hepatic impairment. J Antimicrob Chemother. 2008; DOI: 10.1093/jac/dkn212

Linnebacher M; Blauscha C; Wacke R; Kottek T; Stein v S; Kiefel V; Hakenberg OW; Klar E: AN In Vitro System for the Determination of Individualized Immunosuppression. Transplantation Proceedings, 2008, 40, 918 – 20

Majcher-Peszynska J; Haase G; Saß M; Mundkowski R; Pietzsch A; Klammt S; Schareck W; Drewelow B: Pharmacokinetics and penetration of linezolid into inflamed soft tissue in diabetic foot infections.Eur J Clin Pharmacol, 2008, DOI 10.1007/s00228-008-0531-5

Lange S; Mueller SC; Altmann S; Dahlhaus M; Drewelow B; Freund M; Junghanss C: Pharmakokinetics of oral myophenolate mofetil in combination with CSA in dogs after non-myeloablative alligeic hematopoietic stem cell transplantation. Bone Marrow Transplant 2008. 41 (7): 667 – 74


Knoop M; Schütze M; Piek J; Drewelow B; Mundkowski RG: Antibiotic Prophylaxis in Cerebrospinal Fluid Shunting: Evaluation of Cefotiam Penetration into the Human CSF. Zentralbl Neurochir. 2007; 68; 14 - 18 

Thürmann A; Werner U; Hanke F; Schmiedl S; Drewelow B; Hippius M; Reimann I; Siegmund W; Hasford J: Arzneimittelrisiken bei hochbetagten Patienten: Ergebnisse deutscher Studien. Fortschritt und Fortbildung in der Medizin. 2007/2008; Band 31: 216 - 24  

Knoop M; Schütze M; Piek J; Drewelow B; Mundkowski R: Antibiotic Prophylaxis in Cerebrospinal Fluid Shunting: Reassessment of Cefotiam Penetration into Human CSF - Antibiotikaprophylaxe bei Liquorshuntoperationen: Neubewertung der Cefotiampenetration in den menschlichen Liquor. Zentralbl Neurochir 2007; 68: 14 - 18 

Schubert JK; Miekisch W; Fuchs P; Scherzer N; Lord H; Pawliszyn J; Mundkowski RG: Determination of antibiotic drug concentrations in circulating human blood by means of solid phase micro-extraction.Clinica Chimica Acta 2007; 386: 57 - 62 

Derendorf H; Hübner M, Drewelow B; Fuhr U; Gleiter CH; Lemmer B; Mikus G; Roots I; Ziegler A; Ukena D: Ciclesonid – Pharmakokientische und pharmakodynamische Eigenschaften. Arzneimitteltherapie 2007; 25: 89 - 94 

Schmiedl S; Szymanski J; Rottenkolber M; DrewelowB; Haase G; Hippius M; Reimann IR; Siegmund W; May K; Haack S; Hasford J; Thürmann PA: Fingerhut – ein alter Hut? Eine Analyse stationärer Aufnahmen durch digitalisassoziierte unerwünschte Arzneimittelwirkungen. Medizinische Klinik 2007; 102: 603 - 11

Klammt S; Mitzner S; Stange J; Brinkmann B; Drewelow B; Emmrich J; Liebe S; Schmidt R: Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disaese assessed by model for end-stage liver disease. Eur J Gastroenterol Hepatol. 2007; 19: 257 - 63 

Burkhardt O; Kumar V; Katterwe D; Majcher-Peszynska J; Drewelow B; Derendorf H; Welte T: Ertapenem in Critical ill Patients with Early-Onset V AP: Pharmacokinetics with Special Consideration on the Free Drug Concentration. J Antimicrob Chemother. 2007 59: 277 - 84 

Müller S; Drewelow B: Dosierung von Antibiotika bei Sepsis. Infection 2007; 35, Suppl.

S.C. Müller, T. Welte: Arzneimittel-Interaktionen mit systematischen Antimykotika beim Intensivpatienten. Intensivmed 2007 44:526-534 (DOI 10.1007/s00390-007-0828-0; 28. August 2007)

S. Siewert, B. Drewelow, S.C. Müller: Clearance of levofloxacin by an in vitro model of continous venovenous hemodialysis (CVVHD). Int J Artific Organ 2007 30 (10): 889-95

Lange S, Müller SC, Altmann S, Dahlhaus M, Drewelow B, Freund M, Junghanss C: Pharmacokinetics of oral mycophenolate mofetil in combination with CsA in dogs after nonmyeloablative allogeneic homoatopoietic stem cell transplantation. Bone Marrow Transplant 2007 Dec 17 [Epub ahead of print]

Majcher-Peszynska J; Karrasch K; Sa? M; Mundkowski R; Gusmann A; Lübbert C; Kujath P; Ruf B; Schareck W; Koch H; Drewelow B: Pharmakokinetische Untersuchnungen zur Gewebepenetration von Moxifloxacin in nekrobiotische Areale des diabetischen Fuß-Syndromes - eine Zwischenauswertung. Moxifloxacin-DFS-Studiengruppe. Infection; 2007; 35(Suppl.1)

Majcher-Peszynska J; Saß M; Czaika V; Lobmann R; Mundkowski R; Eckhard M; Scheffer B; Gussmann A; Lübbert C; Kujath P; Ruf B;Schareck W; Klar E; Koch H; Drewelow B:Tissue penetration and pharmacokinetics of moxifloxacin at steady state in patients with diabetic foot infections. Moxifloxacin-DFI-study group. Basic & Clinical Pharmacology & Toxicology; 2007; 101(5)


Mueller S; Majcher-Peszynska J; Uehleke B; Klammt S; Mundkowski R; Miekisch W; Sievers H; Bauer S; Frank B; Kundt G; Drewelow B: The extent of induction of CYP3A by St. John’s wort varies among products and is linked to hyperforin dose. Eur J Clin Pharmacol. 62; 2006; 29 - 36 

Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V: Hyperforin in St. John’s wort drug interactions. Eur J Clin Pharmacol., 2006; 62 (3): 225 - 33

Mundkowski RG; Majcher-Peszynska J; Burkhardt O; Welte T; Drewelow B: A new simple HPLC assay fort he quantification of ertapenem in human plasma, lung tissue, and broncho-alveolar lavage fluid.Jchromb. B, 2006; 832; 231 - 35 

Wacke R; Kundt G; Gock M; Klar E; Drewelow B; Schareck W: Pharmacokinetic profiling of cyclosporine microemulsion during the first 3 weeks after simultaneous pancreas-kidney transplantation. Transplant Proc, 2006; 38:751 - 2 

Wacke R; Foerster S; Adam U; Mundkowski R; Klar E; Hopt U; Drewelow B: The Penetration of Moxifloxacin into the Human Pancreas Following a Single Intravenous or Oral Dose.
Journal of Antimicrobial Chemotherapy, 2006 

Thürmann PA; Haack S; Werner U; Szymanski J; Haase G; Drewelow B; Reimann I; Hippius M; Siegmund W; May K; Hasford J: Sex-specific frequency of beta-blocker related hospitalzations. Clin Pharmacology & Therapeutics, 2006, 80 (5) 549 - 60 

Burkhardt O; Kumar V; Katterwe D; Majcher-Peszynska J; Drewelow B; Derendorf H; Welte T: Ertapenem in Critical ill Patients with Early-Onset V AP: Pharmacokinetics with Special Consideration on the Free Drug Concentration. Journal of Antimicrobial Chemotherapy, 2006, JAC-2006-0607.R1 

Thürmann PA; Haack S; Werner U; Szymanski J; Haase G; Drewelow B; Reimann I; Hippius M; Siegmund W; May K; Hasford J: Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is.Clin Pharmacol Ther 2006, 551 - 553 

Siewert S: Validation of a levofloxacin HPLC assay in plasma and dialysate for pharmacokinetic studies. Journal of Pharmaceutical and Biomedical 2006; 41: 1360 - 62


Kohlen K; Haase G; Drewelow B: Codein-bedingte Pankreatitis – ein Fallbericht. Dtsch Med Wochenschr. 130; 2005; 878 - 879 

Burkhardt O; Majcher-Peszynska J; Borner K; Mundkowski R; Drewelow B; Derendorf H; Welte T: Penetration of Ertapenem Into Different Pulmonary Compartments of Patients Undergoing Lung Surgery; J Clin Pharmacol 45; 2005; 659 - 665 

Mitzner S; Klammt S; Stange J; Nöldge-Schomburg GFE; Schmidt R: Extrakorporale Blutreinigung im schweren Leberversagen mit der Albumindialyse MARS® - Einfluss auf intensivmedizinisch relevante Parameter. Anästhesiol Intensivmed Notfallmed Schmerzther 40; 2005; 199 - 206 

Wittemer S M; Ploch M; Windeck T; Müller SC; Drewelow B; Derendorf H; Veit M: Bioavailability and pharmacokinetics of caffeoylquinic acids and flavonoids after oral administration of Artichoke leaf extracts in humans. Phytomedicine 12; 2005; 28 - 38

Majcher-Peszynska J; Drewelow B; Der Diabetische Fuß: Worauf kommt es bei der Auswahl des Antibiotikums an? Klinikarzt 34 (12); 2005; 14-15


Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Pezsynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B: Effect of St. John`s wort dose and preparations on the pharmacokinetics of digoxin.Clin Pharmacol Ther 75; 2004; 546 - 557

Schaarschmidt T; Merkord J; Kunert-Keil S; Sperker B; Schroeder E; Adam U; Drewelow B; Wacke R: Expression of multidrug resistance proteins in rat and human chronic pancreatitis. Pancreas 28; 2004; 45 - 52

Majcher-Peszynska J; Drewelow B; Gewebepenetration von Linezolid. Linezolid: Neue Daten nach Einführung in die Klinik, 2004, 1. Auflage, 35-70


Wigger M; Drückler E; Muscheites J; Stolpe HJ; Kundt G; Wacke R: Comparison of cyclosporine absorption profiles over a 12-month period in stable pediatric renal transplant
recipients. Transplant Proc 35; 2003; 1300 - 1303

Wacke R; Park S; Mundkowski R; Block N; Kuhn-Thiel A; Drewelow B: The penetration of Moxifloxacin into the pancreas of male rats in experimental acute necrotizing pancreatitis. Chemotherapy 49; 2003; 167 - 171

Klotz U; Beil W; Gleiter C; Drewelow B; Garbe E; Gillessen A; Mutschler E: Arzneimittelinteraktionen-Mechanismen und klinische Bedeutung. Internist 44; 2003; 1444 - 1449

Mitzner S; Klammt S; Peszynski P; Stange J; Schmidt R: Einsatz des Leberunterstützungsverfahrens MARS in der Therapie von Patienten mit Leberversagen. Verdauungskrankheiten 21; 2003; 16 - 24


Mueller SC; Majcher-Peszynska J; Hickstein H; Francke A; Pertschy A; Schulz M; Mundkowski R; Drewelow B: Pharmacokinetics of Piperacillin-Tazobactam in Anuric Intensive Care Patients during Continuous Venovenous Hemodialysis. Antimicrob Agents Chemother 46; 2002; 1557 - 1560

Halle E; Majcher-Peszynska J; Drewelow B: Linezolid: Das erste Antibiotikum aus der Klasse der Oxazolidinone: Mikrobiologie und Pharmakologie. Chemotherapie Journal 11; 2002; 1 - 11

Klammt S; Mitzner S; Peszynski P; Stange J: Extracorporale Leberunterstützung durch Albumindialyse. Die gelben Hefte 42; 2002; 147 - 158

Klammt S; Stange J; Mitzner S; Peszynski P; Peters E; Liebe S: Extracorporeal liver support by recirculating albumin dialysis: analysing the effect of the first clinically used generation of the MARSystem.Liver 22; 2002; 30 - 34

Kuse ER; Kotzerke J; Müller S; Nashan B; Lück R; Jaeger K: Hepatic reticuloendothelial function during parenteral nutrition including an MCT/LCT or LCT emulsion after liver transplantation – a double-blind study. Transpl Int 15; 2002; 272 - 277

Peszynski P; Klammt S; Peters E; Mitzner S; Stange J; Schmidt R: Albumin dialysis: single pass vs. recirculation (MARS). Liver 22; 2002; 40 - 42

Heemann U; Treichel U; Loock J; Philipp T; Gerken G; Malago M; Klammt S; Lohr JM; Liebe S; Mitzner S; Schmidt R; Stange J: Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatology 36; 2002; 946 - 958

Wigger M; Armstrong VW; Shipkova M; Wacke R; Nizze H; Streit F; von Ahsen N; Muscheites J; Glasenapp S; Stolpe HJ; Oellerich M: Atypical pharmacokinetics and metabolkism of mycophenolic acid in a young kidney transplant recipient with impaired renal function. Ther Drug Monit 24; 2002; 438 - 443

Pietzsch M; Theuer S; Haase G; Plath F; Keyser M; Riethling AK: Results of systematic screening for serious gastrointestinal bleeding associated with NSAIDs in Rostock hospitals.
Int J Clin Pharmacol Ther 40; 2002; 111 - 115

Schneeweiss J; Hasford J; Göttler M; Hoffmann AM; Riethling AK; Avorn J: Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 58; 2002; 285 - 29 

Haase G; Pietzsch M; Fähnrich A; Voss W; Riethling AK: Results of a systematic adverse drug reaction (ADR)-sreening concerning bradycardia causing by drug interactions in departments of internal medicine in Rostock. Int J Clin Pharmacol Ther 40; 2002; 116 - 119

Werner U; Werner D; Pahl A; Mundkowski R; Gillich M; Brune K: Investigation of the pharmacokinetics of celecoxib by liquid chromatography-mass spectrometry. Biomed Chromatogr 16; 2002; 56 - 60

Heemann U; Treichel U; Loock J; Philipp T; Gerken G; Malago M; Klammt S; Loehr M; Liebe S; Mitzner S; Rodes J: Albumin dialysis in cirrhosis with superimposed acute liver injury. A prospective, controlled study.Hepatology 36; 2002; 949 - 958

Mitzner S; Loock J; Peszynski P; Klammt S; Majcher-Peszynska J; Gramowski A; Stange J; Schmidt R: Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS-a review of clinical, biochemical, and electrophysiological data. Metab Brain Dis 17; 2002; 463 - 475


Uehleke B; Steinhoff B: Self-medication in Germany. Int J Clin Pharmacol Ther 39; 2001; 484 - 487

Hehl EM: Opinion on the use of the antitumor drug trastzumab (Herceptin) in patients with metastasic breast cancer in the county Mecklenburg-Vorpommern. Int J Clin Pharmacol Ther 39; 2001; 503 - 506 

Graefe EU; Wittig J; Mueller S; Riethling AK; Drewelow B; Pforte H; Jacobasch G; Derendorf H; Veit M: Pharmacokinetics and bioavailability of quercetin glycosides in humans. J Clin Pharmacol 41; 2001; 492 - 499

Majcher-Peszynska J; Peszynski P; Müller SC; Klammt S; Wacke R; Mitzner S; Stange J; Mundkowski R; Hehl EM; Schmidt R; Drewelow B: Drugs in liver disease and during albumin dialysis – MARS.Z Gastroenterologie 39; 2001; 33 - 35 

Wacke R; Drewelow B; Kundt G; Hehl EM; Bast R; Seiter H: Cyclosporine A: peak or trough level monitoring in renal transplant recipients. Transplant Proc 33; 2001; 3122 - 3123 

Wigger M; Drückler E; Muscheites J; Stolpe HJ; Kundt G; Wacke R: Cyclosporine peak concentration in relation to four-hour absorption phase in pediatric renal graft recipients. Transplant Proc 33; 2001, 3126 - 3127 

Werner U; Werner D; Mundkowski RG; Gilich M; Brune K: Selektive and rapid liquid chromatography-mass spectrometry method for the quantification of rofecoxib in pharmacokinetic studies with humans. J Chromatogr B 760; 2001; 83 - 90

Marsch GA; Mundkowski RG; Morris JB; Manier ML; Hartmann KM; Guengrich FP: Characterization of nucleoside and DNA adducts formed by S- (1-acetoxymethyl) glutathione and implications for dihalomethanes-glutathione conjugates. Chem Res Toxicol 14; 2001, 600 - 608

Adam U; Herms S; Werner U; Strubelt H; Makowiec F; Hopt UT; Drewelow B: The penetration of ciprofloxacin into human pancreatic and peripancreatic necroses in acute necrotizing
pancreatitis. Infection 29; 2001; 326 - 331

Schneeweiss S; Göttler M; Hasford J; Swoboda W; Hippius M; Hoffmann A; Riethling AK; Krappweis J: First results from an intensified monitoring system to estimate drug related hospital admissions. J Clin Pharmacol 52, 2001, 196 - 200


Wacke W; Rohde B; Engel G; Kundt G; Hehl EM; Bast R; Seiter H; Drewelow B: Comparison of several approaches of therapeutic drug monitoring of cyclosporine A based on individual pharmacokinetics.Eur J Clin Pharmacol 56; 2000; 43 - 48

Henkel KO; Mueller SC; Hehl EM; Härtel J; Drewelow B: Penetration von Clindamycin zur perioperativen Prophylaxe bei intraoralen Eingriffen. Die Quintessenz 51; 2000; 1135 - 1141  

Sperker B; Werner U; Mürdter TE; Tekkaya C; Fritz P; Wacke R; Adam U; Gerken M; Drewelow B; Kroemer HK: Expression and function of ß-glucuronidase in healthy pancreas, chronic pancreatitis and pancreatic cancer: Potential role in drug targeting. Naunyn Schmiedebergs Arch Pharmacol 362; 2000; 110 - 115